A new study led by Bucknell University Professor Karlo Malaga, biomedical engineering, has identified key insights into optimizing deep brain stimulation (DBS) for Parkinson's disease patients.

A groundbreaking international clinical trial has been testing an implanted adaptive deep brain stimulation (aDBS) device as a treatment therapy for Parkinson’s.

The Department of Neurology and Neurological Sciences at Stanford University School of Medicine, together with multiple academic medical centers and one industry partner (Medtronic) across the US, ...

ST. PAUL, Minn., March 21 (UPI) --Parkinson's disease patients and advocates are marking the start of a new era for treatment of the illness, as a doctors deploy a breakthrough neurological device for ...

Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the FDA’s approval for its adaptive, closed-loop neurostimulation approach to ...

Abbott’s Infinity Deep Brain Stimulation (DBS) system has received an expanded clearance from the FDA that now permits the targeted stimulation of a new area of the brain associated with Parkinson’s ...

TUESDAY, Oct. 7, 2025 (HealthDay News) — Deep brain stimulation (DBS) implants can provide long-term relief for people with Parkinson’s disease, a new study says. Parkinson’s patients who got deep ...

London - The doctors prepared to carry out the brain surgery, their medical tools laid out. Their patient, wide awake on the operating table, was given an instrument of her own: her clarinet, which ...

Medtronic has won FDA approval for a device that can help with therapy for those suffering from Parkinson’s Disease. The Dublin-based company’s BrainSense Adaptive deep brain stimulation (aDBS) and ...

Please provide your email address to receive an email when new articles are posted on . The adaptive deep brain stimulation technology is the first of its kind to address symptoms of Parkinson’s ...